These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
123 related articles for article (PubMed ID: 502351)
1. [Effect of BCNU on glutathione metabolism in human blood cells]. Benöhr HC; Waller HD Klin Wochenschr; 1979 Aug; 57(16):845-50. PubMed ID: 502351 [TBL] [Abstract][Full Text] [Related]
2. Mechanism of inhibition of red blood cell glutathione reductase activity by BCNU (1,3-bis(2-chloroethyl)-1-nitrosourea). Shinohara K; Tanaka KR Clin Chim Acta; 1979 Mar; 92(2):147-52. PubMed ID: 39688 [TBL] [Abstract][Full Text] [Related]
3. Glutathione reductase deficiency and platelet dysfunction induced by 1,3-bis(2-chloroethyl)-1-nitrosourea. McKenna R; Ahmad T; Ts'ao CH; Frischer H J Lab Clin Med; 1983 Jul; 102(1):102-15. PubMed ID: 6687896 [TBL] [Abstract][Full Text] [Related]
4. Characterization of the inhibition of glutathione reductase and the recovery of enzyme activity in exponentially growing murine leukemia (L1210) cells treated with 1,3-bis(2-chloroethyl)-1-nitrosourea. Cohen MB; Duvel DL Biochem Pharmacol; 1988 Sep; 37(17):3317-20. PubMed ID: 3401259 [TBL] [Abstract][Full Text] [Related]
5. Glutathione reductase-deficient erythrocytes as host cells of malarial parasites. Zhang Y; König I; Schirmer RH Biochem Pharmacol; 1988 Mar; 37(5):861-5. PubMed ID: 3278713 [TBL] [Abstract][Full Text] [Related]
6. Effects of 1,3-bis(2-chloroethyl)-1-nitrosourea (BCNU) on the levels of glutathione and lipid peroxidation and the activity of glutathione reductase in liver and lung. Nakagawa Y Toxicol Lett; 1987 Feb; 35(2-3):269-75. PubMed ID: 3824416 [TBL] [Abstract][Full Text] [Related]
7. Severe generalized glutathione reductase deficiency after antitumor chemotherapy with BCNU" [1,3-bis(chloroethyl)-1-nitrosourea]. Frischer H; Ahmad T J Lab Clin Med; 1977 May; 89(5):1080-91. PubMed ID: 870569 [TBL] [Abstract][Full Text] [Related]
8. Differential inhibition of cellular glutathione reductase activity by isocyanates generated from the antitumor prodrugs Cloretazine and BCNU. Rice KP; Penketh PG; Shyam K; Sartorelli AC Biochem Pharmacol; 2005 May; 69(10):1463-72. PubMed ID: 15857610 [TBL] [Abstract][Full Text] [Related]
9. The effects of BCNU (1,3-bis(2-chloroethyl)-1-nitrosourea) and CCNU (1-(2-chloroethyl)-3-cyclohexyl-1-nitrosourea) on glutathione reductase and other enzymes in mouse tissue. Maker HS; Weiss C; Brannan TS Res Commun Chem Pathol Pharmacol; 1983 Jun; 40(3):355-66. PubMed ID: 6622814 [TBL] [Abstract][Full Text] [Related]
10. Inhibition of human glutathione reductase by the nitrosourea drugs 1,3-bis(2-chloroethyl)-1-nitrosourea and 1-(2-chloroethyl)-3-(2-hydroxyethyl)-1-nitrosourea. A crystallographic analysis. Karplus PA; Krauth-Siegel RL; Schirmer RH; Schulz GE Eur J Biochem; 1988 Jan; 171(1-2):193-8. PubMed ID: 3338461 [TBL] [Abstract][Full Text] [Related]
11. Reduction of glutathione levels in livers of mice treated with N,N'-bis (2-chloroethyl)-N-nitrosourea. McConnell WR; Kari P; Hill DL Cancer Chemother Pharmacol; 1979; 2(3):221-3. PubMed ID: 455578 [TBL] [Abstract][Full Text] [Related]
12. Preferential effects of 1,3-bis(2-chloroethyl)-1-nitrosourea (BCNU) on pulmonary glutathione reductase and glutathione/glutathione disulfide ratios: possible implications for lung toxicity. Smith AC; Boyd MR J Pharmacol Exp Ther; 1984 Jun; 229(3):658-63. PubMed ID: 6726651 [TBL] [Abstract][Full Text] [Related]
13. Active site-specific inhibition by 1,3-bis(2-chloroethyl)-1-nitrosourea of two genetically homologous flavoenzymes: glutathione reductase and lipoamide dehydrogenase. Ahmad T; Frischer H J Lab Clin Med; 1985 Apr; 105(4):464-71. PubMed ID: 3920338 [TBL] [Abstract][Full Text] [Related]
14. The effect of BCNU (carmustine) on tissue glutathione reductase activity. Kehrer JP Toxicol Lett; 1983 Jun; 17(1-2):63-8. PubMed ID: 6623510 [TBL] [Abstract][Full Text] [Related]
15. Glutathione reductase inhibitors as potential antimalarial drugs. Effects of nitrosoureas on Plasmodium falciparum in vitro. Zhang YA; Hempelmann E; Schirmer RH Biochem Pharmacol; 1988 Mar; 37(5):855-60. PubMed ID: 3278712 [TBL] [Abstract][Full Text] [Related]
16. Enhanced oxygen toxicity following treatment with 1,3-bis(2-chloroethyl)-1-nitrosourea. Kehrer JP; Paraidathathu T Fundam Appl Toxicol; 1984 Oct; 4(5):760-7. PubMed ID: 6510607 [TBL] [Abstract][Full Text] [Related]
17. The effect of BCNU and adriamycin on normal and G6PD deficient erythrocytes. Sagone AL; Burton GM Am J Hematol; 1979; 7(2):97-106. PubMed ID: 539595 [TBL] [Abstract][Full Text] [Related]
18. Consequences of erythrocytic glutathione reductase deficiency. Frischer H; Ahmad T J Lab Clin Med; 1987 May; 109(5):583-8. PubMed ID: 3572207 [TBL] [Abstract][Full Text] [Related]
19. The role of glutathione reductase in maintaining human granulocyte function and sensitivity to exogenous H2O2. Cohen HJ; Tape EH; Novak J; Chovaniec ME; Liegey P; Whitin JC Blood; 1987 Feb; 69(2):493-500. PubMed ID: 3801665 [TBL] [Abstract][Full Text] [Related]
20. Depletion in vitro of mitochondrial glutathione in rat hepatocytes and enhancement of lipid peroxidation by adriamycin and 1,3-bis(2-chloroethyl)-1-nitrosourea (BCNU). Meredith MJ; Reed DJ Biochem Pharmacol; 1983 Apr; 32(8):1383-8. PubMed ID: 6860357 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]